// App-Quantinova.ai

10598 : Impact of race on biomarker testing among HER2- advanced breast cancer (ABC) patients (pts) in the United States: Results from a real-world study.

Researchers

Presenter

  • Reshma L. Mahtani

Principal Investigators

  • Alexander Niyazov

  • Katie Lewis

  • Lucy Massey

  • Alex Rider

  • Bhakti Arondekar

  • Michael P Lux

Medical Centers

  • Sylvester Cancer Center, University of Miami, Deerfield Beach, FL, Pfizer Inc., New York, NY, Adelphi Real World, Bollington, United Kingdom

  • Kooperatives Brustzentrum Paderborn, Frauenklinik St. Louise, Paderborn, St. Josefs-Krankenhaus, Salzkotten, Frauen- und Kinderklinik St. Louise, Paderborn, Germany

Locations

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Breast cancer type 1 susceptibility protein

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Programmed death-ligand 1

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved